| Host: |
HEK293 cells |
| Reactivity: |
SARS-CoV |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Recombinant-SARS-CoV Spike S1+S2 ECD (S-ECD)-C-His protein was developed from hek293 cells and has a target region of C-His. For use in research applications. |
| Formulation: |
Supplied as a 0.22 Mu m filtered solution in PBS, pH 7.4. |
| Immunogen Region: |
Ser14-Pro1195 |
| Immunogen: |
Recombinant SARS-CoV S1+S2 ECD ( S-ECD ) Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Ser14-Pro1195) of sars-cov S1+S2 ECD ( S-ECD ) (Accession #NP_828851.1) fused with a 6×His tag at the C-ter |
| Background | Recombinant SARS-CoV S1+S2 ECD ( S-ECD ) Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Ser14-Pro1195) of sars-cov S1+S2 ECD ( S-ECD ) (Accession #NP_828851.1) fused with a 6×His tag at the C-terminus. |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
